[Current status and future of clinical kidney transplantation in Japan].

Takashi Kenmochi, Kenichi Saigo, Michihiro Maruyama, Naotake Akutsu, Takehide Asano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Kidney transplantation has been established to be the therapy for an end-stage renal disease. In Japan, living donor kidney transplantation is frequently performed (> 80%) because of a shortage of the deceased donors. The graft survival has been improved to 93.4% (5-year graft survival in living donor kidney transplantation after 2001). ABO-incompatible cases are increasing and more than 20% are ABO-incompatible in Japan (30% in our institution). In our institution, 225 kidney transplantations (182: living donors, 43: deceased donors) have been performed from 2004.4 to 2010.6. Although the graft survival is excellent, posttransplant infections including cytomegalovirus, EB virus and BK virus are problems which should be solved. For the safety of the recipients, we should use kidney grafts from brain-dead donors.

Original languageEnglish
Pages (from-to)2291-2295
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Volume68
Issue number12
Publication statusPublished - 01-12-2010
Externally publishedYes

Fingerprint

Kidney Transplantation
Living Donors
Japan
Graft Survival
Tissue Donors
BK Virus
Brain Death
Cytomegalovirus Infections
Chronic Kidney Failure
Viruses
Transplants
Kidney
Safety
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kenmochi, Takashi ; Saigo, Kenichi ; Maruyama, Michihiro ; Akutsu, Naotake ; Asano, Takehide. / [Current status and future of clinical kidney transplantation in Japan]. In: Nippon rinsho. Japanese journal of clinical medicine. 2010 ; Vol. 68, No. 12. pp. 2291-2295.
@article{5a98aa23d7fb4ea499b95569d91668b3,
title = "[Current status and future of clinical kidney transplantation in Japan].",
abstract = "Kidney transplantation has been established to be the therapy for an end-stage renal disease. In Japan, living donor kidney transplantation is frequently performed (> 80{\%}) because of a shortage of the deceased donors. The graft survival has been improved to 93.4{\%} (5-year graft survival in living donor kidney transplantation after 2001). ABO-incompatible cases are increasing and more than 20{\%} are ABO-incompatible in Japan (30{\%} in our institution). In our institution, 225 kidney transplantations (182: living donors, 43: deceased donors) have been performed from 2004.4 to 2010.6. Although the graft survival is excellent, posttransplant infections including cytomegalovirus, EB virus and BK virus are problems which should be solved. For the safety of the recipients, we should use kidney grafts from brain-dead donors.",
author = "Takashi Kenmochi and Kenichi Saigo and Michihiro Maruyama and Naotake Akutsu and Takehide Asano",
year = "2010",
month = "12",
day = "1",
language = "English",
volume = "68",
pages = "2291--2295",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "12",

}

[Current status and future of clinical kidney transplantation in Japan]. / Kenmochi, Takashi; Saigo, Kenichi; Maruyama, Michihiro; Akutsu, Naotake; Asano, Takehide.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 68, No. 12, 01.12.2010, p. 2291-2295.

Research output: Contribution to journalArticle

TY - JOUR

T1 - [Current status and future of clinical kidney transplantation in Japan].

AU - Kenmochi, Takashi

AU - Saigo, Kenichi

AU - Maruyama, Michihiro

AU - Akutsu, Naotake

AU - Asano, Takehide

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Kidney transplantation has been established to be the therapy for an end-stage renal disease. In Japan, living donor kidney transplantation is frequently performed (> 80%) because of a shortage of the deceased donors. The graft survival has been improved to 93.4% (5-year graft survival in living donor kidney transplantation after 2001). ABO-incompatible cases are increasing and more than 20% are ABO-incompatible in Japan (30% in our institution). In our institution, 225 kidney transplantations (182: living donors, 43: deceased donors) have been performed from 2004.4 to 2010.6. Although the graft survival is excellent, posttransplant infections including cytomegalovirus, EB virus and BK virus are problems which should be solved. For the safety of the recipients, we should use kidney grafts from brain-dead donors.

AB - Kidney transplantation has been established to be the therapy for an end-stage renal disease. In Japan, living donor kidney transplantation is frequently performed (> 80%) because of a shortage of the deceased donors. The graft survival has been improved to 93.4% (5-year graft survival in living donor kidney transplantation after 2001). ABO-incompatible cases are increasing and more than 20% are ABO-incompatible in Japan (30% in our institution). In our institution, 225 kidney transplantations (182: living donors, 43: deceased donors) have been performed from 2004.4 to 2010.6. Although the graft survival is excellent, posttransplant infections including cytomegalovirus, EB virus and BK virus are problems which should be solved. For the safety of the recipients, we should use kidney grafts from brain-dead donors.

UR - http://www.scopus.com/inward/record.url?scp=79952116095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952116095&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 2291

EP - 2295

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 12

ER -